GCIPolarean’s Chris von Jako: “I’ve been bringing new and important life changing medical technologies to market for 30 years”
Vox Markets speaks to Chris von Jako, chief executive of (POLX ), about the company’s five pillar strategy to drive uptake of its life saving lung imaging technology.
0:29 Chris von Jako describes the progress the company’s made on the regulatory and commercial front since he joined as CEO last June.
3:57 Discusses Chris’s 30 years of experience in overcoming the challenges of bringing new medical devices to market.
6:54 Details of the company’s XENOVIEW technology, and how it offers clinicians a unique and highly effective approach lung diagnostics.
11:14 Insurance support and other ways Polarean is planning to drive take up of the technology.
13:44 The importance of partnerships as a route to market, and progress identifying new partners alongside Phillips
15:13 Financing requirements for the five-pillar strategy and where it could take Polarean commercially.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.